Fenofibrate choline is a prescription medication used to lower elevated triglyceride levels in adults [1]. It is also used to reduce the risk of heart attack, stroke, and other heart problems in adults with certain risk factors [1]. The drug is a combination of fenofibrate and choline [1].
What is Fenofibrate Choline Used For?
Fenofibrate choline's primary use is to manage hypertriglyceridemia, a condition characterized by very high levels of triglycerides in the blood [1]. Elevated triglycerides are a risk factor for cardiovascular disease [2]. By reducing these levels, fenofibrate choline aims to mitigate the risk of serious cardiovascular events such as heart attacks and strokes, particularly in individuals who also have other risk factors like diabetes, high blood pressure, or high cholesterol [1].
How Does Fenofibrate Choline Work?
Fenofibrate choline belongs to a class of drugs called fibrates [1]. It works by altering the levels of fats in the blood. Specifically, fenofibrate, the active component, decreases the production of triglycerides in the liver and increases the breakdown of triglycerides in the bloodstream [1]. It also has beneficial effects on cholesterol levels, often lowering LDL ("bad") cholesterol and raising HDL ("good") cholesterol [3]. The choline component is believed to enhance the absorption and stability of fenofibrate [1].
When Does Fenofibrate Choline Patent Expiration Occur?
Information on the specific patent expiration dates for fenofibrate choline can be found through specialized resources [4]. Drug patent information is dynamic and can be affected by various legal and regulatory factors [4].
What are the Potential Side Effects of Fenofibrate Choline?
Common side effects associated with fenofibrate choline can include upper abdominal pain, back pain, diarrhea, nausea, vomiting, and an increase in liver enzymes [1]. More serious, though less common, side effects can involve the liver, pancreas, kidneys, and muscles [1]. Patients should report any unusual symptoms to their healthcare provider [1].
How Does Fenofibrate Choline Compare to Other Fibrate Medications?
Fenofibrate choline is one of several fibrate medications available. Other fibrates include fenofibric acid (available in various formulations), gemfibrozil, and bezafibrate [3]. While all fibrates work on similar pathways to manage lipid levels, they may differ in their pharmacokinetic profiles, efficacy in reducing specific lipids, side effect profiles, and drug-drug interaction potential [3]. For example, fenofibric acid is a metabolite of fenofibrate, and some formulations are designed for improved absorption [3].
Are There Generic Versions of Fenofibrate Choline Available?
The availability of generic versions of fenofibrate choline depends on the expiration of its associated patents and exclusivity periods [4]. Once these protections expire, other pharmaceutical companies can develop and market generic equivalents, often leading to reduced costs [4].
What are the Risks of Taking Fenofibrate Choline?
While effective, fenofibrate choline carries potential risks. These include liver toxicity, pancreatitis (inflammation of the pancreas), and rhabdomyolysis (a severe muscle condition) [1]. Patients with gallbladder disease, liver disease, or severe kidney disease should use fenofibrate choline with caution or avoid it altogether [1]. It can also interact with other medications, such as warfarin, increasing the risk of bleeding [1].
What Clinical Data Supports the Use of Fenofibrate Choline?
Clinical trials have demonstrated the efficacy of fenofibrate choline in significantly reducing triglyceride levels and lowering the risk of cardiovascular events in high-risk patients [1, 5]. These studies form the basis for its regulatory approval and clinical recommendation [1, 5].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/fenofibrate-choline
[2] https://www.drugpatentwatch.com/drugs/hypertriglyceridemia
[3] https://www.drugpatentwatch.com/drug-classes/fibrates
[4] https://www.drugpatentwatch.com/patents/fenofibrate-choline
[5] https://www.drugpatentwatch.com/drug-trials/fenofibrate-choline